American Healthcare REIT (NYSE:AHR) Releases Quarterly Earnings Results, Misses Estimates By $0.35 EPS

American Healthcare REIT (NYSE:AHR) announced its quarterly earnings results on Tuesday. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.35), Zacks reports. American Healthcare REIT had a negative return on equity of 1.96% and a negative net margin of 1.84%. The firm had revenue of $523.81 million for the quarter, compared to analyst estimates of $474.26 million. The business’s quarterly revenue was up 12.8% on a year-over-year basis. American Healthcare REIT updated its FY24 guidance to $1.40-1.43 EPS and its FY 2024 guidance to 1.400-1.430 EPS.

American Healthcare REIT Stock Performance

Shares of American Healthcare REIT stock traded down $0.39 on Thursday, reaching $26.41. The stock had a trading volume of 707,573 shares, compared to its average volume of 1,450,831. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.29 and a current ratio of 0.29. The business’s 50-day moving average price is $25.16 and its two-hundred day moving average price is $19.21. The stock has a market cap of $3.48 billion and a P/E ratio of -55.84. American Healthcare REIT has a fifty-two week low of $12.63 and a fifty-two week high of $27.77.

American Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 18th. Investors of record on Friday, September 20th were paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 3.79%. The ex-dividend date was Friday, September 20th. American Healthcare REIT’s payout ratio is -208.33%.

Wall Street Analyst Weigh In

Several brokerages have weighed in on AHR. JMP Securities lifted their price target on shares of American Healthcare REIT from $18.00 to $30.00 and gave the company a “market outperform” rating in a research report on Friday, September 20th. Morgan Stanley lifted their target price on shares of American Healthcare REIT from $17.00 to $22.00 and gave the company an “overweight” rating in a report on Thursday, August 22nd. KeyCorp raised their price target on American Healthcare REIT from $16.00 to $27.00 and gave the stock an “overweight” rating in a research report on Monday, September 16th. Truist Financial boosted their price target on shares of American Healthcare REIT from $22.00 to $27.00 and gave the stock a “buy” rating in a research note on Friday, September 20th. Finally, Colliers Securities raised shares of American Healthcare REIT from a “hold” rating to a “moderate buy” rating in a research report on Sunday, October 13th. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $23.00.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.